“…In 2006, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposed three minimal properties for defining human MSCs: plastic adherence, multilineage differentiation (chondrocytes, osteoblasts, and adipocytes), and the expression of specific markers (CD105, CD73, and CD90) [ 9 ]. MSCs and their conditioned media (CM) are considered to be promising in regenerative–reparative medicine, cell therapy, and tissue engineering [ 10 , 11 , 12 , 13 , 14 ] due to their effects on tissue and organ homeostasis, revascularization, and tissue repair, as well as their immunomodulatory, anti-inflammatory, pro-angiogenic, pleiotropic, and tropic abilities. For this reason, considerable efforts have been made to introducing advanced MSC-based therapy into clinical practice.…”